We are Marshall

Nothing says home court advantage to IP plaintiffs more than the Eastern District of Texas. Claimed patent owners have won 77 percent of trials there, compared with 59 percent nationwide, according to Bloomberg’s story. http://www.bloomberg.com/apps/news?pid=20601202&sid=a8uzH470Q4gw

Today was no exception as Johnson & Johnson, represented by Texas trial dynamos Sayles Werbner and Dianne Elderkin of Philadelphia’s Woodcock Washburn, nailed Abbott Labs for $1.67 billion for infringing J&J’s arthritis medication, Remicade, to create its own rheumatoid arthritis drug, Humira. It is reportedly the largest patent verdict ever, eclipsing the $1.53 billion verdict against Microsoft by Alcatel/Lucent from the Southern District of California. That verdict was later overturned.

Judge T. John Ward had previously denied a motion to dismiss in the Texas matter. J&J claims that NYU, which joined it as a co-plaintiff, holds the patent and licensed it to the Centocor division of J&J.

The case is one chapter in an ongoing battle between the two medical powerhouses. Another infringment action is pending in Massachusetts.

The nation’s leading IP eminence, William Lee of WilmerHale, took today’s loss, assisted by local counsel David Beck of Houston’s Beck Redden.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s